Related Experiment Videos
Samuel Reincke1,2, Maryuri Delgado1,2, Julia Vogler1,2
1Klinik für Rhythmologie, Universitäres Herzzentrum Lübeck, Universitätsklinikum Schleswig-Holstein, Lübeck, Deutschland.
Insights
New European Society of Cardiology guidelines address challenging bradycardia diagnosis and treatment. They include updated recommendations for cardiac pacing therapies, syncope, and bundle branch block, incorporating conduction system pacing.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Guidelines
Context:
- Bradycardia diagnosis and treatment present challenges due to abnormalities in cardiac structures.
- Recent European Society of Cardiology (ESC) guidelines offer updated recommendations.
Purpose:
- To optimize the assessment and treatment of patients experiencing bradycardia.
- To integrate new therapeutic approaches into clinical practice.
Summary:
- The guidelines cover diagnostics, reflex syncope management, and treatment algorithms for syncope and bundle branch block.
- Leadless pacemakers are considered for specific patient groups.
- Conduction system pacing is introduced as a physiological stimulation method.
Impact:
- Provides clinicians with updated evidence-based strategies for managing bradycardia.
- Facilitates the adoption of advanced pacing techniques like conduction system pacing.
- Enhances patient care through optimized cardiac pacemaker and resynchronization therapy recommendations.
Abstract:
Abnormalities of the sinus node, atrial tissue, atrioventricular node tissue, and specialized conduction system can all contribute to bradycardia. For this reason, the diagnosis and treatment of bradycardia have become challenging. In order to further optimize the assessment and treatment of patients with bradycardia, new guidelines on cardiac pacemaker therapy and cardiac resynchronization therapy were published by the European Society of Cardiology (ESC) last year. These include new recommendations for diagnostics, dealing with reflex syncope and treatment algorithms for syncope and bundle branch block. The use of leadless pacemakers is being discussed in selected and especially multimorbid patients as an alternative to conventional transvenous pacemaker implantation. Conduction system pacing as a physiological form of stimulation was included in the guidelines for the first time.